Episode | Initial identification | Final identification | Infection focus | Treatment |
(I) 5 July 06 | S aureus in 6/6 bottles | S aureus | Mitral valve endocarditis | Cefuroxime 1.5 g BID, rifampicin 300 mg TID and fucidic acid 500 mg TID for 6 weeks |
(II) 31 Aug 06 | CoNS in 6/9 bottles | S aureus (CoNS contaminant in one of the bottles) | Unknown* | Dicloxacillin 2 g TID, vancomycin 1 g QD and fucidic acid 500 mg TID for 3 weeks, afterwards vancomycin 1 g QD for further 3 weeks. |
(III) 2 Nov 06 | S aureus and CoNS in 9/9 bottles | S aureus (CoNS contaminant in one of the bottles) | Unknown* | Cefuroxime 1.5 g BID, vancomycin 1 g QD and fucidic acid 500 mg TID for 2 weeks and, subsequently, rifampicin 600 mg BID and fucidic acid 500 mg TID for 7 weeks |
(IV) 9 Feb 07 | S. aureus and CoNS in 9/9 bottles | S aureus | Unknown* | Cefuroxime 1.5 g BID and vancomycin 1 g QD for 2 weeks |
(V) 14 March 07 | S aureus in 3/3 bottles | S aureus | Unknown* | Cefuroxime 3 g QD and vancomycin 1 g QD for 4 weeks followed by continuous cefuroxime axetil 1 g BID prophylactic treatments |
*Infection focus in episodes II, III, IV and IV were assumed to be a pacemaker.
BID, twice daily; CoNS, coagulase negative Staphylococcus; QD, four times daily; TID, three times daily.